Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Cash Flows from Operating Activities:
Net Loss		$ (166,362)
Adjustments to Reconcile Net Loss to Net Cash Used In Operating Activities:
Depreciation and Amortization		25,000
Interest accrued		17,175
Issuance of stock as compensation expense		34,000
Stock options expensed		8,853
Changes in assets and liabilities:
Accounts Receivable		(8,158)
Inventory		$ 21,343
Prepaid expenses
Other assets
Accounts Payable and Accrued Expenses		$ 18,284
Other current liabilities
Net Cash Used In Operating Activities		$ (49,865)
Cash Flows from Financing Activities:
Proceeds from Related Parties		$ 58,838
Proceeds from stock subscription
Cash flow provided by financing activities		$ 58,838
Increase (Decrease) in Cash and Cash Equivalents		(8,973)
Cash and Cash Equivalents - Beginning of period		1,855
CASH AND CASH EQUIVALENTS - END OF PERIOD		10,828
Schedule of Non-Cash Financing Activities:
Issuance of Common Stock to settle or convert debt		$ 15,000
Reduction in liability for unissued shares
Restated [Member]
Cash Flows from Operating Activities:
Net Loss	$ (1,571,498)
Adjustments to Reconcile Net Loss to Net Cash Used In Operating Activities:
Depreciation and Amortization
Interest accrued
Issuance of stock as compensation expense	$ 1,347,224
Stock options expensed
Changes in assets and liabilities:
Accounts Receivable
Inventory	$ (26,770)
Prepaid expenses	(218)
Other assets	2,300
Accounts Payable and Accrued Expenses	(167,046)
Other current liabilities	121,001
Net Cash Used In Operating Activities	(295,007)
Cash Flows from Financing Activities:
Proceeds from Related Parties	6,000
Proceeds from stock subscription	334,623
Cash flow provided by financing activities	340,623
Increase (Decrease) in Cash and Cash Equivalents	45,616
Cash and Cash Equivalents - Beginning of period	8,272
CASH AND CASH EQUIVALENTS - END OF PERIOD	53,888
Schedule of Non-Cash Financing Activities:
Issuance of Common Stock to settle or convert debt	542,776
Reduction in liability for unissued shares	$ 10,000